BioNexus Gene Lab Receivables 2019-2024 | BGLC
BioNexus Gene Lab Annual Receivables (Millions of US $) |
|
---|---|
2023 | $1 |
2022 | $3 |
2021 | $3 |
2020 | $4 |
2019 | $0 |
2018 | $0 |
BioNexus Gene Lab Quarterly Receivables (Millions of US $) |
|
---|---|
2024-09-30 | $2 |
2024-06-30 | $1 |
2024-03-31 | $1 |
2023-12-31 | $1 |
2023-09-30 | $1 |
2023-06-30 | $2 |
2023-03-31 | $3 |
2022-12-31 | $3 |
2022-09-30 | $3 |
2022-06-30 | $3 |
2022-03-31 | $3 |
2021-12-31 | $3 |
2021-09-30 | $4 |
2021-06-30 | $4 |
2021-03-31 | $4 |
2020-12-31 | $4 |
2020-09-30 | $0 |
2020-06-30 | $0 |
2020-03-31 | $0 |
2019-12-31 | $0 |
2019-09-30 | $0 |
2019-06-30 | $0 |
2019-03-31 | $0 |
2018-12-31 | $0 |
2018-09-30 | |
2018-06-30 | |
2018-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.006B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $90.619B | 11.24 |
Cencora (COR) | United States | $47.732B | 17.95 |
DiDi Global (DIDIY) | China | $22.844B | 0.00 |
Natera (NTRA) | United States | $22.698B | 0.00 |
ICON (ICLR) | Ireland | $16.752B | 14.92 |
Avantor (AVTR) | United States | $15.042B | 22.55 |
Revvity (RVTY) | United States | $14.943B | 25.96 |
BioMerieux (BMXMF) | France | $13.831B | 0.00 |
Viatris (VTRS) | United States | $13.297B | 4.10 |
CochLear (CHEOY) | Australia | $13.090B | 0.00 |
Solventum (SOLV) | United States | $12.725B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.729B | 30.23 |
Doximity (DOCS) | United States | $10.460B | 61.57 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.632B | 0.00 |
HealthEquity (HQY) | United States | $9.166B | 45.99 |
Charles River Laboratories (CRL) | United States | $8.602B | 16.62 |
Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
Bausch + Lomb (BLCO) | Canada | $6.016B | 27.98 |
Organon (OGN) | United States | $4.087B | 4.12 |
Sotera Health (SHC) | United States | $3.852B | 20.61 |
BrightSpring Health Services (BTSG) | United States | $3.690B | 78.48 |
Concentras Parent (CON) | United States | $2.819B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.801B | 0.00 |
Surgery Partners (SGRY) | United States | $2.587B | 29.49 |
PACS (PACS) | United States | $2.147B | 0.00 |
Premier (PINC) | United States | $2.116B | 11.01 |
GeneDx Holdings (WGS) | United States | $2.082B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.075B | 0.00 |
Progyny (PGNY) | United States | $1.801B | 36.47 |
GoodRx Holdings (GDRX) | United States | $1.795B | 47.10 |
Teladoc Health (TDOC) | United States | $1.701B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
Agilon Health (AGL) | United States | $1.463B | 0.00 |
CareDx (CDNA) | United States | $1.244B | 0.00 |
Pediatrix Medical (MD) | United States | $1.208B | 11.82 |
Embecta (EMBC) | United States | $1.089B | 7.62 |
AMN Healthcare Services Inc (AMN) | United States | $1.022B | 6.91 |
Establishment Labs Holdings (ESTA) | $1.014B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.609B | 0.00 |
SBC Medicals (SBC) | United States | $0.521B | 0.00 |
InnovAge Holding (INNV) | United States | $0.501B | 0.00 |
DocGo (DCGO) | United States | $0.448B | 16.89 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
Enhabit (EHAB) | United States | $0.398B | 34.39 |
MultiPlan (MPLN) | United States | $0.259B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.255B | 0.00 |
Sera Prognostics (SERA) | United States | $0.220B | 0.00 |
LifeMD (LFMD) | United States | $0.220B | 0.00 |
Beauty Health (SKIN) | United States | $0.207B | 0.00 |
Nutex Health (NUTX) | United States | $0.207B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.189B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.105B | 17.80 |
Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
ModivCare (MODV) | United States | $0.077B | 4.20 |
IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Oncology Institute (TOI) | United States | $0.053B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.033B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
KindlyMD (KDLY) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |